These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 33961868)

  • 21. Adaptation and implementation of the "Kidney Disease: Improving Global Outcomes (KDIGO)" guidelines for evaluation and management of mineral and bone disorders in chronic kidney disease for practice in the Middle East countries.
    Al Rukhaimi M; Al Sahow A; Boobes Y; Goldsmith D; Khabouth J; El Baz T; Mahmoud H; Ganji MR; Shaheen FA;
    Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):133-48. PubMed ID: 24434398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference.
    Ostermann M; Bellomo R; Burdmann EA; Doi K; Endre ZH; Goldstein SL; Kane-Gill SL; Liu KD; Prowle JR; Shaw AD; Srisawat N; Cheung M; Jadoul M; Winkelmayer WC; Kellum JA;
    Kidney Int; 2020 Aug; 98(2):294-309. PubMed ID: 32709292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review.
    Sarnak MJ; Amann K; Bangalore S; Cavalcante JL; Charytan DM; Craig JC; Gill JS; Hlatky MA; Jardine AG; Landmesser U; Newby LK; Herzog CA; Cheung M; Wheeler DC; Winkelmayer WC; Marwick TH;
    J Am Coll Cardiol; 2019 Oct; 74(14):1823-1838. PubMed ID: 31582143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Marwick TH; Amann K; Bangalore S; Cavalcante JL; Charytan DM; Craig JC; Gill JS; Hlatky MA; Jardine AG; Landmesser U; Newby LK; Herzog CA; Cheung M; Wheeler DC; Winkelmayer WC; Sarnak MJ;
    Kidney Int; 2019 Oct; 96(4):836-849. PubMed ID: 31543156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference.
    Babitt JL; Eisenga MF; Haase VH; Kshirsagar AV; Levin A; Locatelli F; Małyszko J; Swinkels DW; Tarng DC; Cheung M; Jadoul M; Winkelmayer WC; Drüeke TB;
    Kidney Int; 2021 Jun; 99(6):1280-1295. PubMed ID: 33839163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KDOQI US Commentary on the KDIGO 2020 Clinical Practice Guideline for Diabetes Management in CKD.
    Mottl AK; Alicic R; Argyropoulos C; Brosius FC; Mauer M; Molitch M; Nelson RG; Perreault L; Nicholas SB
    Am J Kidney Dis; 2022 Apr; 79(4):457-479. PubMed ID: 35144840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and risk factors of peripheral artery disease in a population with chronic kidney disease in Australia: A systematic review and meta-analysis.
    Ho CLB; Chih HJ; Garimella PS; Matsushita K; Jansen S; Reid CM
    Nephrology (Carlton); 2021 Oct; 26(10):798-808. PubMed ID: 34156137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD).
    Uhlig K; Berns JS; Kestenbaum B; Kumar R; Leonard MB; Martin KJ; Sprague SM; Goldfarb S
    Am J Kidney Dis; 2010 May; 55(5):773-99. PubMed ID: 20363541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Canadian Society of Nephrology commentary on the KDIGO clinical practice guideline for CKD evaluation and management.
    Akbari A; Clase CM; Acott P; Battistella M; Bello A; Feltmate P; Grill A; Karsanji M; Komenda P; Madore F; Manns BJ; Mahdavi S; Mustafa RA; Smyth A; Welcher ES
    Am J Kidney Dis; 2015 Feb; 65(2):177-205. PubMed ID: 25511161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal therapeutic strategy for those with chronic kidney disease and peripheral artery disease receiving peripheral vascular intervention.
    Imamura T
    Clin Cardiol; 2020 Dec; 43(12):1348. PubMed ID: 33073876
    [No Abstract]   [Full Text] [Related]  

  • 31. Peripheral Artery Disease: Its Adverse Consequences With and Without CKD.
    Bourrier M; Ferguson TW; Embil JM; Rigatto C; Komenda P; Tangri N
    Am J Kidney Dis; 2020 May; 75(5):705-712. PubMed ID: 31879218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defining AKD: The Spectrum of AKI, AKD, and CKD.
    Levey AS
    Nephron; 2022; 146(3):302-305. PubMed ID: 34167119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of patients with diabetes and CKD: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
    Perkovic V; Agarwal R; Fioretto P; Hemmelgarn BR; Levin A; Thomas MC; Wanner C; Kasiske BL; Wheeler DC; Groop PH;
    Kidney Int; 2016 Dec; 90(6):1175-1183. PubMed ID: 27884312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The CKD Outcomes and Practice Patterns Study (CKDopps): Rationale and Methods.
    Mariani L; Stengel B; Combe C; Massy ZA; Reichel H; Fliser D; Pecoits-Filho R; Lopes AA; Yamagata K; Wada T; Wong MM; Speyer E; Port FK; Pisoni RL; Robinson BM
    Am J Kidney Dis; 2016 Sep; 68(3):402-13. PubMed ID: 27113505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors and safe contrast volume thresholds for postcontrast acute kidney injury after peripheral vascular interventions.
    Lee SR; Zhuo H; Zhang Y; Dahl N; Dardik A; Ochoa Chaar CI
    J Vasc Surg; 2020 Aug; 72(2):603-610.e1. PubMed ID: 31843298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of Specialty Nephrology Care Among Patients With Chronic Kidney Disease and High Risk of Disease Progression.
    Wang M; Peter SS; Chu CD; Tuot DS; Chen JH
    JAMA Netw Open; 2022 Aug; 5(8):e2225797. PubMed ID: 35984661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of anemia in chronic kidney disease--position statement of the Croatian Society for Nephrology, Dialysis and Transplantation and review of the KDIGO and ERPB guidelines].
    Rački S; Bašić-Jukić N; Kes P; Ljutić D; Lovčić V; Prkačin I; Radić J; Vujičić B; Bubić I; Jakić M; Belavić Ž; Sefer S; Pehai M; Klarić D; Gulin M;
    Acta Med Croatica; 2014 Apr; 68(2):215-21. PubMed ID: 26012163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global perspective of kidney diseases: Challenges and changes.
    Nangaku M
    Nephrology (Carlton); 2023 Aug; 28 Suppl 1():5-7. PubMed ID: 37534846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spanish Society of Nephrology document on KDIGO guidelines for the assessment and treatment of chronic kidney disease.
    Gorostidi M; Santamaría R; Alcázar R; Fernández-Fresnedo G; Galcerán JM; Goicoechea M; Oliveras A; Portolés J; Rubio E; Segura J; Aranda P; de Francisco AL; Del Pino MD; Fernández-Vega F; Górriz JL; Luño J; Marín R; Martínez I; Martínez-Castelao A; Orte LM; Quereda C; Rodríguez-Pérez JC; Rodríguez M; Ruilope LM
    Nefrologia; 2014 May; 34(3):302-16. PubMed ID: 24798565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Chronic Kidney Disease With In-Hospital Outcomes of Transcatheter Aortic Valve Replacement.
    Gupta T; Goel K; Kolte D; Khera S; Villablanca PA; Aronow WS; Bortnick AE; Slovut DP; Taub CC; Kizer JR; Pyo RT; Abbott JD; Fonarow GC; Rihal CS; Garcia MJ; Bhatt DL
    JACC Cardiovasc Interv; 2017 Oct; 10(20):2050-2060. PubMed ID: 29050621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.